Utilising non-canonical amino acids in the design of artificial enzymes: an exploration of Cu-enzymes, steroid carrier protein scaffolds and synthetic biology
Item Status
Embargo End Date
Date
Authors
Klemenčič, Eva
Abstract
Artificial metalloenzymes (ArMs) merge the selectivity of enzymes and reactivity
of transition metals, bringing novel reactivity into the field of biocatalysis.
However, ArMs are a relatively new field and there are still many unknowns that
need to be explored for the catalysts to be applied in industry.
In this work, the design of novel Cu(II) ArMs using human sterol carrier protein
(SCP_2L) scaffold was investigated to study sterol carrier protein (SCP) as
privileged scaffold for artificial enzyme design. The SCP_2L scaffold was
modified to contain a 2,2’-bipyridine side chain to create a novel, site-selective
metal binding site for Cu(II) ions and thus generating a catalytically active site in
the SCP_2L protein scaffold. The 2,2’-bipyridine moiety was either bioconjugated
to SCP_2L via unique cysteines residues or incorporated as unnatural amino acid
(UAA) (2,2’-bipyridin-5-yl)alanine (BpyAla) using genetic code expansion (GCE).
The novel Cu(II) ArMs show moderate initial selectivity in the enantioselective
Friedel-Crafts alkylation reaction. The most promising catalyst was the
SCP_Q111BpyAla mutant that exhibited induced product enantioselectivity of
60% e.e. The X-ray structures of the SCP_Q111CBpy_Cu and
SCP_Q111BpyAla_Cu were solved, showing a different orientation of 2,2'-
bipyridine in the protein environment as a result of different modification
strategies. An alanine scan of nearby residues to the Cu in SCP_Q111Bpy_Cu
was conducted, and the mutants were tested in the Friedel-Crafts reaction. None
of the mutants were found to conclusively favour or disfavour catalysis, and
current work is looking to use computational methods to help optimise the
catalytic activity. The work improved the understanding of ArMs as looking at the
same ligand and reaction through different modification strategies. Overall, the
results demonstrate that the SCP_2L scaffold could be used as a scaffold for the
design of ArMs using both genetic code expansion and bioconjugation methods.
A limitation of the SCP-2L scaffold for unnatural reactions is the relative instability
to metal ions and temperature. A survey of the protein crystallographic database
(PDB) revealed two known structures of steroid carrier proteins from thermophilic
organisms. SCP from Thermus thermophilus (TT_SCP) was chosen as a scaffold
to expand the reaction scope of the SCP-based ArMs to be able to catalyse
reactions at higher temperatures and in the presence of solvents. Residues W83,
L87, A96, and L102 were identified as potential sites for bioconjugation via
computational analysis. To date, W83 and L102 were successfully obtained using
site-directed mutagenesis and expressed in good yield. Nano differential
scanning fluorimetry (NanoDSF), circular dichroism (CD) and thermal shift assay
(TSA) were used to assess the chemical stability and thermostability of human
SCP_2L and TT_SCP. From the initial studies, TT_SCP seems to be more stable
than human SCP_2L with Tm higher than 95 °C. Initial bioconjugation studies of
TT_SCP show successful attachment of phenanthroline ligand and Cu binding.
Unnatural amino acids (UAAs) are valuable additions to the genetic code for the
design of new artificial enzymes. However, industrial use of this technology is
unknown in part due to the need to synthesize the amino acid in large quantities.
As a technology development project, a self-sustainable E. coli chemical factory
was designed to produce UAA para-aminophenylalanine (pAF) using three genes
of the biosynthetic pathway papABC. PapA, papB, and papC were designed to
be compatible with the JUMP platform to facilitate pathway optimisation and
provide a system for UAAs offering a high throughput screening of biosynthetic
pathways. The selective incorporation of pAF into LmrR protein scaffold was
achieved and the artificial enzyme catalysed the hydrazone formation in silico.
This item appears in the following Collection(s)

